BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel


NEWSLETTERS
FREENewsletters
Archive

NEWS
News bySubject
News byDisease
News byDate
PLoS
SearchNews

CAREER NETWORK
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

DIVERSITY

HOTBEDS
Regional News
BiotechBay™
BiotechBeach™
Genetown™
PharmCountry™
BioCapital™
BioMidwest™
BioNC™
BioForest™
SouthernPharm™
BioCanadaEast™
US Device™

INVESTOR
Market Summary
News
IPOs

PROFILES
CompanyProfiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event

RESOURCES
RealEstate
Business Opportunities
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Regenerx Biopharmaceuticals, Inc. (OP: RGRX)
0.0800 USD  -0.0070 (-8.05%)
Official Closing Price  /  Updated: 8:10 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 3,000
Open 0.0870
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0870
Today's Range 0.0800 - 0.0870
52wk Range 0.0425 - 0.1700
Shares Outstanding 81,733,247
Dividend Yield N/A
Top News
More News
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
May 20, 2013
Medium and large sized pharmaceutical companies were down by an average of .3-.6% at the closing bell Jumps by % Gain and Mkt Cap Change Biolife Solutions (OTC: BLFS) +34% on spike in trading activity... Read More
category RPTP , ACAD , MDXG , and 15 more.
from Bio-Wire.Com
RegeneRx Issues Letter to Sharholders
May 13, 2013
from Business Wire News Releases

More News
Read More
RegeneRx Issues $225,000 Convertible Note
April 01, 2013
from Business Wire News Releases
RegeneRx Receives Notice of Allowance for 2nd U.S. Heart Patent
March 08, 2013
from Business Wire News Releases
RegeneRx Receives Notice of Allowance from Chinese Patent Office for Treatment and Prevention of Heart Disease
February 07, 2013
from Business Wire News Releases
RegeneRx Receives Notice of Allowance from U.S. Patent Office for New Ophthalmic Indications
November 05, 2012
from Business Wire News Releases
RegeneRx Issues $300,000 Convertible Note To Pursue Current Initiatives
October 22, 2012
from Business Wire News Releases
RegeneRx Receives Key Ophthalmic Patent in Mexico
September 13, 2012
from Business Wire News Releases
RegeneRx’s T?4 Promotes Recovery of Peripheral Neuropathy in Type II Diabetic Mice
August 29, 2012
from Business Wire News Releases
The Week in Review: Jinhe Biotech Stages $79 Million IPO in Shenzhen
July 21, 2012
from ChinaBio® Today
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
About BioSpace | Contact Us | Privacy Statement | Terms of Use
Post Your News | Post Event | Post Jobs | Post Company Profile | Advertising Opportunities

RSS FEED All News | Breaking News | Featured Stories

© 2007 BioSpace, Inc - an onTargetjobs company
Visit other onTargetjobs companies
Niche Job Boards | Biotechnology Jobs | Healthcare Jobs | Nursing Jobs | Accounting Jobs | Hospitality Jobs
Hospitality Jobs Canada | Hospitality Jobs UK